RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: autoimmune disease of gastrointestinal tract
Accession: DOID:0060031
browse the term
Definition: An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the gastrointestinal tract. (DO)
Synonyms: narrow_synonym: IMMUNODEFICIENCY AND AUTOIMMUNE ENTEROCOLOPATHY
G
NFAT5
nuclear factor of activated T cells 5
ISO
ClinVar Annotator: match by term: Immunodeficiency and Autoimmune Enterocolopathy
ClinVar
PMID:28492532
NCBI chr 5:79,995,292...80,115,116
Ensembl chr 5:80,003,587...80,115,096
G
ATP4B
ATPase H+/K+ transporting subunit beta
ISO
RGD
PMID:7517707 PMID:8393475
RGD:14696740 RGD:14696746
NCBI chr22:60,898,801...60,904,223
Ensembl chr22:60,898,833...60,904,223
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:19301087
RGD:5686833
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
ALDOB
aldolase, fructose-bisphosphate B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16115720
NCBI chr11:58,150,621...58,166,266
Ensembl chr11:58,150,967...58,176,319
G
B9D2
B9 domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
C1S
complement C1s
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11390518
NCBI chr27:37,976,196...37,985,846
Ensembl chr27:37,976,197...37,989,575
G
CCL2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 9:39,008,187...39,009,932
G
CCL5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
G
CD274
CD274 molecule
ISO
RGD
PMID:19781375
RGD:41412171
NCBI chr 1:93,461,735...93,605,772
Ensembl chr 1:93,585,518...93,603,522
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility
ISO
DNA:SNPs:exons:49A>G (rs231775), CT60 C > T(rs3087243)(human)
RGD
PMID:30320190
RGD:14398726
NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
G
CYP2D15
cytochrome P450 family 2 subfamily D member 15
ISO
protein:increased expression:serum:
RGD
PMID:3186722 PMID:10435724
RGD:11353781 RGD:7207226
NCBI chr10:23,255,259...23,259,380
Ensembl chr10:23,255,249...23,259,298
G
DLA-DQB1
major histocompatibility complex, class II, DQ beta 1
ISO
DNA:polymorphism (human)
RGD
PMID:17050030 PMID:20007077
RGD:5147584 RGD:5147634
NCBI chr12:2,305,307...2,307,711
G
DNASE1
deoxyribonuclease 1
ISO
protein:decreased activity:serum (human)
RGD
PMID:28263100
RGD:38500241
NCBI chr 6:37,596,735...37,599,953
Ensembl chr 6:37,595,911...37,599,827
G
F2
coagulation factor II, thrombin
disease_progression
ISO
RGD
PMID:20821236 PMID:21711423
RGD:5147750 RGD:5147775
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
FAS
Fas cell surface death receptor
treatment
ISO
protein:increased expression:lymphocyte:
RGD
PMID:26429926 PMID:28551553
RGD:14700710 RGD:14700711
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:28551553
RGD:14700710
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
G
HLA-DRB1
MHC class II DLA DRB1 beta chain
susceptibility
ISO
DNA:polymorphisms (human) DNA:polymorphism (human) DNA:polymorphisms: :multiple (human)
RGD
PMID:10573514 PMID:11182227 PMID:15763345 PMID:17050030
RGD:5147634 RGD:5147652 RGD:5147810 RGD:5147856
NCBI chr12:2,151,409...2,164,564
G
HRAS
HRas proto-oncogene, GTPase
ISO
human gene in a mouse model
RGD
PMID:9195373
RGD:14694814
NCBI chr18:25,642,844...25,644,717
Ensembl chr18:25,642,844...25,644,717
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL13
interleukin 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
G
IL18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
G
IL2
interleukin 2
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21227906 PMID:29233784 PMID:29323192
RGD:14747037 RGD:14747042
NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
G
IL21
interleukin 21
exacerbates
ISO
protein:increased expression:blood serum, peripheral blood mononuclear cell (human)
RGD
PMID:27386263
RGD:127285554
NCBI chr19:17,641,833...17,651,275
Ensembl chr19:17,641,833...17,651,266
G
IL22
interleukin 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr10:10,487,367...10,492,238
Ensembl chr10:10,487,262...10,492,371
G
IL4
interleukin 4
susceptibility treatment
ISO
DNA:SNPs:promoter:-590C>T,-33T>C (human) protein:increased expression:serum: CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21227906 PMID:26735262 PMID:30034292
RGD:14696677 RGD:14696683
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
IL5
interleukin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr11:20,825,469...20,827,269
Ensembl chr11:20,825,469...20,827,269
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
IL9
interleukin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr11:23,808,919...23,814,085
Ensembl chr11:23,811,117...23,814,079
G
LEP
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
G
MIR155
microRNA mir-155
treatment
ISO
RGD
PMID:29420849 PMID:30290123
RGD:21081535 RGD:21409750
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR223
microRNA mir-223
treatment
ISO
RGD
PMID:29145157 PMID:31826604
RGD:21408546 RGD:21408563
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
PDCD1
programmed cell death 1
ISO
RGD
PMID:19781375 PMID:23869988
RGD:40818236 RGD:41412171
NCBI chr25:51,606,559...51,618,903
Ensembl chr25:51,608,173...51,618,723
G
PDCD1LG2
programmed cell death 1 ligand 2
ISO
RGD
PMID:19781375
RGD:41412171
NCBI chr 1:93,631,676...93,698,560
Ensembl chr 1:93,631,979...93,689,266
G
PDIA3
protein disulfide isomerase family A member 3
ISO
RGD
PMID:20208391
RGD:9999172
NCBI chr30:10,487,926...10,513,437
Ensembl chr30:10,487,921...10,513,397
G
STAT4
signal transducer and activator of transcription 4
susceptibility
ISO
DNA:SNPs: intron 3, intron: (rs7574865, rs7582694) (human)
RGD
PMID:23990947 PMID:28977835
RGD:25671418 RGD:25671419
NCBI chr37:1,566,563...1,685,378
Ensembl chr37:1,566,585...1,829,894
G
TNF
tumor necrosis factor
ISO
protein:increased expression:serum (human)
RGD
PMID:9047083
RGD:14995307
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
VDR
vitamin D receptor
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:15683428
RGD:14402024
NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:plasma:
RGD
PMID:26615570
RGD:11538286
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
ZFHX3
zinc finger homeobox 3
ISO
protein:increased expression:blood serum (human)
RGD
PMID:20534899
RGD:151361169
NCBI chr 5:78,450,963...78,635,615
Ensembl chr 5:78,455,005...78,610,033
G
ACE
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
APOB
apolipoprotein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr17:15,877,937...15,916,032
Ensembl chr17:15,878,244...15,915,135
G
APOC3
apolipoprotein C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 5:16,744,423...16,746,992
Ensembl chr 5:16,744,423...16,746,992
G
ASAH2
N-acylsphingosine amidohydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr26:37,136,601...37,228,215
Ensembl chr26:37,136,897...37,218,783
G
BACH2
BTB domain and CNC homolog 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr12:49,101,621...49,375,415
Ensembl chr12:49,106,523...49,460,286
G
CAPN8
calpain 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 7:40,408,408...40,451,843
Ensembl chr 7:40,408,141...40,452,068
G
CCR4
C-C motif chemokine receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr23:3,844,072...3,847,770
Ensembl chr23:3,844,173...3,845,255
G
CD14
CD14 molecule
ISO
associated with Diabetes Mellitus, Insulin-Dependent;DNA:SNP:promoter:
RGD
PMID:18728522
RGD:2314152
NCBI chr 2:35,790,505...35,792,967
G
CD36
CD36 molecule (CD36 blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr18:20,299,808...20,375,856
Ensembl chr18:20,339,050...20,372,639
G
CD80
CD80 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr33:23,177,136...23,208,421
Ensembl chr33:23,177,138...23,201,380
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility
ISO
ClinVar Annotator: match by term: Celiac disease, susceptibility to, 3 | ClinVar Annotator: match by term: GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 3
ClinVar OMIM
PMID:8817351 PMID:9259273 PMID:9398726 PMID:10189842 PMID:10475192 PMID:11098935 PMID:11158025 PMID:12724780 PMID:15138458 PMID:15199380 PMID:15301861 PMID:15688186 PMID:24033266 PMID:25741868 PMID:26884280 PMID:27102614 PMID:27577878 PMID:28492532 PMID:30377434 PMID:30940614 More...
NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
G
CXCL11
C-X-C motif chemokine ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr32:631,084...636,997
Ensembl chr32:631,478...632,868 Ensembl chr32:631,478...632,868
G
DLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
ISO
DNA:polymorphism (human)
OMIM RGD
PMID:17919990
RGD:5147625
NCBI chr12:2,305,307...2,307,711
G
ETS1
ETS proto-oncogene 1, transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 5:6,059,023...6,189,516
Ensembl chr 5:6,058,935...6,186,232
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:23556408
RGD:7387257
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
GBP5
guanylate binding protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 6:59,273,699...59,292,563
Ensembl chr 6:59,273,592...59,393,229
G
HLA-DRB1
MHC class II DLA DRB1 beta chain
ISO
DNA:polymorphisms (human)
RGD
PMID:12404952
RGD:5147803
NCBI chr12:2,151,409...2,164,564
G
ICOS
inducible T cell costimulator
susceptibility
ISO
DNA:SNP,haplotype: :rs10932037(human)
RGD
PMID:19020530
RGD:11344917
NCBI chr37:12,663,839...12,735,266
Ensembl chr37:12,670,999...12,733,458
G
ICOSLG
inducible T cell costimulator ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr31:38,084,861...38,094,743
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:26440733 PMID:30097691
RGD:14974259
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IL10
interleukin 10
ISO
RGD
PMID:27545437
RGD:14975156
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL15
interleukin 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23269601
NCBI chr19:1,339,607...1,364,762
Ensembl chr19:1,339,967...1,364,762
G
IL21
interleukin 21
susceptibility
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (human)
CTD RGD
PMID:17558408 PMID:22077623
RGD:127285362
NCBI chr19:17,641,833...17,651,275
Ensembl chr19:17,641,833...17,651,266
G
IL23R
interleukin 23 receptor
susceptibility
ISO
DNA:SNP:cds:p.R381Q(rs11209026)(human)
RGD
PMID:18368064 PMID:19175939
RGD:8549604 RGD:8549631
NCBI chr 5:43,307,422...43,369,806
Ensembl chr 5:43,308,982...43,368,474
G
IL6
interleukin 6
ISO
associated with Diabetes Mellitus, Insulin-Dependent; DNA:polymorphism:promoter:-174G>C (human)
RGD
PMID:18692934
RGD:2307292
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
LCN2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 9:55,328,118...55,342,535
Ensembl chr 9:55,328,133...55,332,038
G
LOC478984
low affinity immunoglobulin gamma Fc region receptor III
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr38:21,054,870...21,060,948
G
LPL
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr25:37,078,306...37,102,729
Ensembl chr25:37,079,756...37,102,700
G
LRAT
lecithin retinol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr15:52,399,773...52,409,590
Ensembl chr15:52,399,544...52,406,176
G
MMP12
matrix metallopeptidase 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 5:28,918,626...28,933,404
Ensembl chr 5:28,918,594...28,933,309
G
MMP3
matrix metallopeptidase 3 (stromelysin 1, progelatinase)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
G
MYO9B
myosin IXB
susceptibility
ISO
ClinVar Annotator: match by term: Celiac disease, susceptibility to, 4 | ClinVar Annotator: match by term: GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 4
OMIM ClinVar
PMID:15822038 PMID:16282976 PMID:25741868 PMID:28492532
NCBI chr20:45,512,286...45,582,619
Ensembl chr20:45,512,276...45,582,619
G
PCK1
phosphoenolpyruvate carboxykinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr24:42,538,858...42,544,200
Ensembl chr24:42,538,882...42,544,198
G
PIWIL2
piwi like RNA-mediated gene silencing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr25:34,911,120...34,987,287
Ensembl chr25:34,912,358...34,987,339
G
PON1
paraoxonase 1
ISO
mRNA:decreased expression:duodenum
RGD
PMID:17664137
RGD:5509924
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
PON3
paraoxonase 3
ISO
mRNA:decreased expression:duodenum
RGD
PMID:17664137
RGD:5509924
NCBI chr14:20,615,180...20,642,807
Ensembl chr14:20,565,641...20,642,985
G
RUNX3
RUNX family transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
G
S100A9
S100 calcium binding protein A9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 7:43,566,993...43,570,074
G
SLC6A14
solute carrier family 6 member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr X:88,939,176...88,965,093
Ensembl chr X:88,938,727...88,965,101
G
SOAT2
sterol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr27:2,053,063...2,062,773
Ensembl chr27:2,053,067...2,062,329
G
TFF1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr31:36,681,478...36,684,571
Ensembl chr31:36,681,357...36,695,665
G
TFRC
transferrin receptor
ISO
mRNA,protein:increased expression:duodenum:
RGD
PMID:15054143
RGD:11062102
NCBI chr33:29,206,024...29,237,221
Ensembl chr33:29,208,609...29,238,242
G
TGM2
transglutaminase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17190764
NCBI chr24:26,631,339...26,662,723
Ensembl chr24:26,628,009...26,663,840
G
THEMIS
thymocyte selection associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 1:66,363,172...66,540,272
Ensembl chr 1:66,363,125...66,540,327
G
TNFRSF14
TNF receptor superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 5:57,386,190...57,416,864
Ensembl chr 5:57,411,529...57,416,512
G
TNFRSF9
TNF receptor superfamily member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 5:61,548,972...61,562,019
Ensembl chr 5:61,551,405...61,560,667
G
UBD
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr35:26,426,919...26,436,189
G
UPB1
beta-ureidopropionase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr26:28,194,968...28,225,977
Ensembl chr26:28,195,081...28,225,567
G
VNN1
vanin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 1:25,678,039...25,704,579
Ensembl chr 1:25,678,042...25,696,807
G
ZMIZ1
zinc finger MIZ-type containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 4:28,807,368...29,035,946
Ensembl chr 4:28,854,908...29,045,986
G
UTP4
UTP4 small subunit processome component
ISO
ClinVar Annotator: match by term: Hereditary North American Indian childhood cirrhosis
ClinVar
PMID:9536098 PMID:12417987 PMID:16225863 PMID:17576681 PMID:19732766 PMID:20385600 PMID:22916032 PMID:24123366 PMID:25741868 PMID:27535533 PMID:28492532 More...
NCBI chr 5:80,474,219...80,508,953
Ensembl chr 5:80,406,084...80,508,981
G
ABCA1
ATP binding cassette subfamily A member 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:28660384
RGD:21203516
NCBI chr11:60,761,669...60,869,753
Ensembl chr11:60,761,655...60,890,496
G
ABCB4
ATP binding cassette subfamily B member 4
treatment disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype, diplotype: : rs31658, rs31672,rs1149222(human)
CTD RGD
PMID:18671305 PMID:20040336 PMID:21209952 PMID:30682444
RGD:14694982 RGD:153297773
NCBI chr14:13,542,610...13,614,334
Ensembl chr14:13,548,462...13,614,571
G
ABCC2
ATP binding cassette subfamily C member 2
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
CTD RGD
PMID:15542527 PMID:15770136
RGD:14700810
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
G
ABCG2
ATP binding cassette subfamily G member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542527
NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
G
ACE
angiotensin I converting enzyme
ISO
mRNA:increased expression:liver
RGD
PMID:19389807
RGD:2325226
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ACE2
angiotensin converting enzyme 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:17532087
RGD:9685452
NCBI chr X:11,798,839...11,839,591
Ensembl chr X:11,798,839...11,900,594
G
AGT
angiotensinogen
ISO
protein:increased expression:plasma
RGD
PMID:17532087
RGD:9685452
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
G
AQP4
aquaporin 4
ISO
RGD
PMID:20451280
RGD:5148030
NCBI chr 7:61,855,617...61,868,953
Ensembl chr 7:61,855,744...61,865,089
G
B9D2
B9 domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
CCL5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver:
CTD RGD
PMID:12126966 PMID:15770052
RGD:14995336
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
G
CCN2
cellular communication network factor 2
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19371232
RGD:2314517
NCBI chr 1:25,508,082...25,511,058
Ensembl chr 1:25,507,662...25,510,145
G
CD3D
CD3 delta subunit of T-cell receptor complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 5:15,392,841...15,396,745
Ensembl chr 5:15,389,243...15,396,750
G
CD80
CD80 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr33:23,177,136...23,208,421
Ensembl chr33:23,177,138...23,201,380
G
CDH5
cadherin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 5:82,830,505...82,863,931
Ensembl chr 5:82,830,939...82,863,882
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:epithelial cell:
RGD
PMID:18456456
RGD:8662434
NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
G
CENPB
centromere protein B
ISO
RGD
PMID:8911074
RGD:27226708
NCBI chr24:17,569,440...17,572,311
Ensembl chr24:17,569,663...17,572,127
G
CLEC16A
C-type lectin domain containing 16A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 6:31,560,940...31,757,100
Ensembl chr 6:31,562,834...31,757,678
G
COL1A1
collagen type I alpha 1 chain
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 9:26,183,852...26,199,927
Ensembl chr 9:26,183,852...26,199,927
G
CPEB1
cytoplasmic polyadenylation element binding protein 1
ISO
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr 3:54,405,140...54,499,614
Ensembl chr 3:54,405,717...54,500,221
G
CPEB4
cytoplasmic polyadenylation element binding protein 4
ISO
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr 4:38,604,065...38,665,200
Ensembl chr 4:38,607,948...38,664,821
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility disease_progression no_association
ISO
autoimmune biliary cirrhosis; DNA:SNP:CDS:49A>G, significant association with G allele (p<0.0002) DNA:SNPs: :rs231775, rs3087243, rs231725 (human) DNA:SNP:CDS:60G>A(rs3087243)(human) DNA:SNP:CDS:49A>G(human)
RGD
PMID:10782900 PMID:16584111 PMID:17482523 PMID:21594562
RGD:14398725 RGD:14398743 RGD:14398744 RGD:2301998
NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21731723
RGD:26884357
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
CXCR5
C-X-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 5:14,921,447...14,932,937
Ensembl chr 5:14,923,089...14,932,762
G
CYGB
cytoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 9:4,191,114...4,201,438
Ensembl chr 9:4,184,959...4,200,164
G
DAG1
dystroglycan 1
ISO
mRNA:increased expression:liver
RGD
PMID:12177244
RGD:2314895
NCBI chr20:39,707,672...39,779,094
Ensembl chr20:39,708,053...39,778,550
G
DENND1B
DENN domain containing 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 7:5,008,249...5,267,392
Ensembl chr 7:4,999,430...5,262,630
G
DNASE1
deoxyribonuclease 1
ISO
protein:decreased activity:serum (human)
RGD
PMID:28263100
RGD:38500241
NCBI chr 6:37,596,735...37,599,953
Ensembl chr 6:37,595,911...37,599,827
G
ENTPD2
ectonucleoside triphosphate diphosphohydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15651265
RGD:9685530
NCBI chr 9:48,589,408...48,594,852
Ensembl chr 9:48,570,891...48,594,452
G
FAS
Fas cell surface death receptor
ISO
protein:increased expression:lymphocyte:
RGD
PMID:26429926
RGD:14700711
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FOXP3
forkhead box P3
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr X:42,331,229...42,362,841
Ensembl chr X:42,344,108...42,350,758
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:20132096
RGD:329970291
NCBI chr 8:30,733,422...30,784,067
Ensembl chr 8:30,732,608...30,784,156
G
HAMP
hepcidin antimicrobial peptide
treatment
ISO
mRNA:decreased expression:liver
RGD
PMID:19652645 PMID:23704825
RGD:11041639 RGD:11041732
NCBI chr 1:117,305,531...117,306,587
Ensembl chr 1:117,305,411...117,306,619
G
HHIP
hedgehog interacting protein
ISO
mRNA:decreased expression:
RGD
PMID:18375471
RGD:11552599
NCBI chr15:43,432,464...43,525,973
Ensembl chr15:43,431,650...43,520,861
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22271822
NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
G
HMOX1
heme oxygenase 1
ISO
mRNA, protein:increased expression:liver, lung
RGD
PMID:12114196
RGD:625603
NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
associated with Graft vs Host Disease;
RGD
PMID:10051478
RGD:11520783
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
ICAM3
intercellular adhesion molecule 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr20:50,777,422...50,783,853
Ensembl chr20:50,777,467...50,783,787
G
IFNG
interferon gamma
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IGFBP1
insulin like growth factor binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr16:1,037,169...1,040,996
Ensembl chr16:1,037,162...1,167,094
G
IL10
interleukin 10
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL12A
interleukin 12A
susceptibility treatment
ISO
DNA:SNPs, haplotype: :rs6441286, rs574808(human) DNA:SNPs:enhancer:rs4679868, rs6441286, rs666251(human) CTD Direct Evidence: marker/mechanism DNA:SNP: :rs62270414(human)
RGD CTD
PMID:19458352 PMID:20639880 PMID:23433321 PMID:27175695
RGD:25440489 RGD:25440498 RGD:25440500
NCBI chr34:26,125,529...26,133,546
Ensembl chr34:26,124,770...26,133,550
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr 4:51,178,637...51,194,606
Ensembl chr 4:51,183,568...51,193,228
G
IL12RB1
interleukin 12 receptor subunit beta 1
susceptibility
ISO
RNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:23910013
RGD:14700865
NCBI chr20:44,885,410...44,908,139
Ensembl chr20:44,885,337...44,904,538
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:20442198
RGD:7829828
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
IL7R
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 4:72,633,528...72,668,242
Ensembl chr 4:72,636,325...72,668,300
G
JAK2
Janus kinase 2
treatment
ISO
RGD
PMID:24619965
RGD:10403061
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
G
KEAP1
kelch like ECH associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr20:50,651,070...50,661,178
Ensembl chr20:50,650,711...50,658,496
G
KRT18
keratin 18
severity
ISO
protein:increased expression:serum (human)
RGD
PMID:26110613
RGD:18337483
NCBI chr27:2,189,269...2,193,368
Ensembl chr27:2,189,269...2,193,368
G
KRT7
keratin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21681009
NCBI chr27:2,812,709...2,827,451
G
LBR
lamin B receptor
ISO
RGD
PMID:8550049
RGD:9588625
NCBI chr 7:39,289,517...39,309,026
Ensembl chr 7:39,288,147...39,307,606
G
LEP
leptin
ISO
protein:decreased expression:serum:
RGD
PMID:16093869
RGD:10411894
NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
G
LEPR
leptin receptor
ISO
protein:increased expression:blood serum
RGD
PMID:16093869
RGD:10411894
NCBI chr 5:44,684,118...44,775,626
Ensembl chr 5:44,688,109...44,775,636
G
LOX
lysyl oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr11:12,023,645...12,040,015
Ensembl chr11:12,027,250...12,039,819
G
LOXL2
lysyl oxidase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr25:34,095,858...34,186,775
Ensembl chr25:34,126,335...34,185,969
G
MAP3K14
mitogen-activated protein kinase kinase kinase 14
ISO
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr 9:18,255,416...18,302,405
Ensembl chr 9:18,280,198...18,302,401
G
MAPK14
mitogen-activated protein kinase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr12:5,145,647...5,221,558
Ensembl chr12:5,146,037...5,220,603
G
MAS1
MAS1 proto-oncogene, G protein-coupled receptor
ISO
RGD
PMID:17532087
RGD:9685452
NCBI chr 1:49,090,041...49,105,244
Ensembl chr 1:49,090,041...49,105,244
G
MET
MET proto-oncogene, receptor tyrosine kinase
severity
ISO
RGD
PMID:19208365
RGD:14694826
NCBI chr14:55,599,047...55,711,626
Ensembl chr14:55,598,337...55,724,027
G
MIR21
microRNA mir-21
severity
ISO
RGD
PMID:28886078
RGD:21408577
NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624
G
MIR223
microRNA mir-223
severity
ISO
RGD
PMID:28886078
RGD:21408577
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
MMEL1
membrane metalloendopeptidase like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639879
NCBI chr 5:57,434,880...57,467,973
Ensembl chr 5:57,434,886...57,465,911
G
MMP13
matrix metallopeptidase 13
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121
G
MMP2
matrix metallopeptidase 2
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP3
matrix metallopeptidase 3 (stromelysin 1, progelatinase)
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
G
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MUC2
mucin 2, oligomeric mucus/gel-forming
ISO
RGD
PMID:18507686
RGD:2324885
NCBI chr18:45,416,347...45,438,226
G
MYBPC2
myosin binding protein C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr 1:106,294,360...106,301,700
Ensembl chr 1:106,266,817...106,301,686
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
G
NFKB1
nuclear factor kappa B subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr32:23,948,598...24,040,704
Ensembl chr32:23,942,954...24,040,703
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression, increased activity:brain (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21903766 PMID:30026087
RGD:5509055
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
NOS3
nitric oxide synthase 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20132096 PMID:30026087
RGD:329970291
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NR1H4
nuclear receptor subfamily 1 group H member 4
susceptibility
ISO
mRNA,protein:decreased expression:liver (human)
RGD
PMID:29968724
RGD:14928336
NCBI chr15:39,497,313...39,608,120
Ensembl chr15:39,536,290...39,608,116
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
mRNA:altered expression:leukocyte, mononuclear
RGD
PMID:15635817
RGD:4892607
NCBI chr 2:38,124,568...38,242,510
Ensembl chr 2:38,123,190...38,240,755
G
NSA2
NSA2 ribosome biogenesis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 2:57,304,160...57,311,836
G
NUP62
nucleoporin 62
severity
ISO
RGD
PMID:12753810
RGD:9831196
NCBI chr 1:106,636,282...106,661,250
G
PDE5A
phosphodiesterase 5A
ISO
RGD
PMID:17610866
RGD:2314466
NCBI chr32:38,272,573...38,407,517
Ensembl chr32:38,244,338...38,407,522
G
PPARGC1A
PPARG coactivator 1 alpha
ISO
mRNA, protein:decreased expression:liver
RGD
NCBI chr 3:85,645,942...86,284,570
Ensembl chr 3:86,016,140...86,281,269
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
REN
renin
ISO
protein:increased activity:plasma (rat)
RGD
PMID:22266601
RGD:6892690
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
RPS6KB1
ribosomal protein S6 kinase B1
ISO
protein:increased expression, increased phosphorylation:liver
RGD
PMID:15769867
RGD:1642977
NCBI chr 9:34,387,084...34,590,603
Ensembl chr 9:34,387,091...34,425,292
G
SLC4A2
solute carrier family 4 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18188457
NCBI chr16:15,111,078...15,126,618
Ensembl chr16:15,111,116...15,126,617
G
SLC51A
solute carrier family 51 member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr33:29,336,000...29,361,782
Ensembl chr33:29,336,552...29,361,738
G
SLC51B
SLC51 subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr30:29,425,489...29,436,204
Ensembl chr30:29,425,860...29,436,073
G
SLCO1C1
solute carrier organic anion transporter family member 1C1
ISO
protein:decreased expression:liver
RGD
PMID:15770136
RGD:14700810
NCBI chr27:26,497,639...26,553,790
Ensembl chr27:26,498,292...26,553,314
G
SOD2
superoxide dismutase 2
ISO
protein:increased expression:serum
RGD
PMID:1682406
RGD:2317411
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
SPINT1
serine peptidase inhibitor, Kunitz type 1
ISO
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr30:7,976,094...7,989,019
Ensembl chr30:7,975,235...7,988,339
G
SPINT2
serine peptidase inhibitor, Kunitz type 2
ISO
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr 1:114,699,050...114,727,802
Ensembl chr 1:114,699,241...114,727,763
G
STAT4
signal transducer and activator of transcription 4
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotypes:multiple DNA:SNPs:3'utr: (rs7574865, rs8179673, rs10181656) (human) DNA:SNP: intron: (rs7574865) (human) associated with Crohn���s disease; DNA:SNP:intron: (rs7574865) (human)
CTD RGD
PMID:21399635 PMID:24648611 PMID:26084578 PMID:28395724
RGD:25671415 RGD:25671416 RGD:25671421
NCBI chr37:1,566,563...1,685,378
Ensembl chr37:1,566,585...1,829,894
G
TJP2
tight junction protein 2
ISO
ClinVar Annotator: match by term: Primary biliary cholangitis
ClinVar
PMID:25741868 PMID:28492532 PMID:32439973
NCBI chr 1:88,126,134...88,251,018
Ensembl chr 1:88,126,136...88,230,654
G
TLR9
toll like receptor 9
ISO
protein:increased expression:liver, peripheral blood mononuclear cell (human)
RGD
PMID:23026026
RGD:18337477
NCBI chr20:37,529,322...37,547,117
Ensembl chr20:37,542,340...37,547,114 Ensembl chr20:37,542,340...37,547,114
G
TNF
tumor necrosis factor
ISO
protein:increased expression:serum (human) mRNA:increased expression:liver
RGD
PMID:9047083 PMID:17158635
RGD:14995307 RGD:38501106
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
TYK2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22961000
NCBI chr20:50,747,145...50,770,008
Ensembl chr20:50,748,329...50,769,216
G
UBD
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr35:26,426,919...26,436,189
G
UTP4
UTP4 small subunit processome component
ISO
North American Indian childhood cirrhosis, OMIM:604901, R565W
RGD
PMID:12417987
RGD:1600653
NCBI chr 5:80,474,219...80,508,953
Ensembl chr 5:80,406,084...80,508,981
G
VDR
vitamin D receptor
susceptibility
ISO
DNA:polymorphism: : DNA:SNP: :
RGD
PMID:15683428 PMID:19376604
RGD:14401750 RGD:14402024
NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:liver protein:increased expression:plasma:
RGD
PMID:26615570 PMID:26627607
RGD:11528851 RGD:11538286
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
ZC3H12A
zinc finger CCCH-type containing 12A
ISO
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr15:4,972,369...4,984,218
Ensembl chr15:4,972,956...4,980,371
G
IL12RB2
interleukin 12 receptor subunit beta 2
ISO
ClinVar Annotator: match by term: IL12RB2-related condition
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 5:43,197,034...43,269,571
Ensembl chr 5:43,197,034...43,257,594
G
LBR
lamin B receptor
ISO
ClinVar Annotator: match by term: PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA | ClinVar Annotator: match by term: Reynolds syndrome
OMIM ClinVar
PMID:18382993 PMID:20522425 PMID:24033266 PMID:25348816 PMID:25741868 PMID:26467025 PMID:28492532 PMID:32827848 More...
NCBI chr 7:39,289,517...39,309,026
Ensembl chr 7:39,288,147...39,307,606
G
ABCB1
ATP binding cassette subfamily B member 1
susceptibility
ISO
RGD
PMID:15505619
RGD:1598568
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
ACSM3
acyl-CoA synthetase medium chain family member 3
ISO
mRNA:decreased expression:colonic mucosa
RGD
PMID:21987487
RGD:7241281
NCBI chr 6:24,558,010...24,594,326
Ensembl chr 6:24,558,142...24,582,728
G
ADCY7
adenylate cyclase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28067910
NCBI chr 2:65,003,891...65,034,812
Ensembl chr 2:65,006,038...65,034,777
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:16432373
RGD:5686726
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
ADRB2
adrenoceptor beta 2
ISO
protein:decreased expression:large intestine mucosa,spleen
RGD
PMID:22772914
RGD:7175063
NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
G
ALOX12
arachidonate 12-lipoxygenase, 12S type
ISO
protein:increased expression:large intestine epithelium
RGD
PMID:7679252
RGD:5509621
NCBI chr 5:32,026,193...32,038,698
Ensembl chr 5:31,882,501...32,038,119
G
ALPI
alkaline phosphatase, intestinal
ISO
protein:decreased expression:colonic mucosa
RGD
PMID:22783049
RGD:14367879
NCBI chr25:44,107,418...44,110,947
G
APLN
apelin
ISO
protein:increased expression:intestine
RGD
PMID:17391779
RGD:1626177
NCBI chr X:100,863,360...100,873,105
G
APOA4
apolipoprotein A4
severity
ISO
DNA:missense mutation:cds:p.Q360H (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17206692 PMID:35999755
RGD:5685660
NCBI chr 5:16,751,588...16,754,215
Ensembl chr 5:16,751,799...16,754,837
G
AQP7
aquaporin 7
severity
ISO
mRNA, protein:decreased expression:colon
RGD
PMID:15338270
RGD:1626292
NCBI chr11:50,474,007...50,488,191
G
ARPC2
actin related protein 2/3 complex subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18836448
NCBI chr37:24,914,389...24,935,998
Ensembl chr37:24,914,642...24,935,824
G
BRINP3
BMP/retinoic acid inducible neural specific 3
ISO
mRNA,protein:decreased expression:intestine
RGD
PMID:25171508
RGD:14398484
NCBI chr38:8,181,227...8,558,518
Ensembl chr38:8,205,916...8,558,482
G
BTNL2
butyrophilin like 2
susceptibility
ISO
DNA:SNPs: : rs2294881,rs9268480,rs2076523(human)
RGD
PMID:19659809
RGD:9685032
NCBI chr12:2,085,589...2,106,787
Ensembl chr12:2,086,324...2,107,124
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
CARD9
caspase recruitment domain family member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 9:49,110,913...49,120,758
Ensembl chr 9:49,113,923...49,120,591
G
CASP3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CCL20
C-C motif chemokine ligand 20
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16306769 PMID:21887805
RGD:7488892
NCBI chr25:40,506,385...40,509,903
Ensembl chr25:40,506,753...40,509,709
G
CCL7
C-C motif chemokine ligand 7
ISO
protein:increased expression:colon
RGD
PMID:10433925
RGD:6483784
NCBI chr 9:38,994,638...38,996,103
Ensembl chr 9:38,993,911...39,010,483
G
CCNY
cyclin Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 2:1,387,962...1,720,497
Ensembl chr 2:1,390,082...1,720,357
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21077277
RGD:6892920
NCBI chr20:42,382,380...42,398,449
Ensembl chr20:42,383,135...42,384,217
G
CCR6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16306769
NCBI chr 1:54,932,798...54,960,646
Ensembl chr 1:54,932,690...54,959,740
G
CD40
CD40 molecule
ISO
protein:increased expression:intestine, epithelial cell
RGD
PMID:20133813
RGD:5490590
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
CDH1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 5:80,757,508...80,834,878
Ensembl chr 5:80,757,508...80,834,878
G
CDH3
cadherin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 5:80,864,859...80,912,136
Ensembl chr 5:80,863,661...80,913,019
G
CDKN1A
cyclin dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:15743319
RGD:8662406
NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
G
CFB
complement factor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr12:1,400,143...1,406,267
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
ISO
mRNA:increased expression:intestine:
RGD
PMID:27051591
RGD:151667910
NCBI chr 3:36,852,082...37,164,930
Ensembl chr 3:36,852,543...36,978,399
G
COL18A1
collagen type XVIII alpha 1 chain
ISO
Protein:increased expression:large intestine mucosa
RGD
PMID:17011522
RGD:1600887
NCBI chr31:38,915,872...38,957,484
G
COL1A1
collagen type I alpha 1 chain
ISO
RGD
PMID:17939044
RGD:5688304
NCBI chr 9:26,183,852...26,199,927
Ensembl chr 9:26,183,852...26,199,927
G
COL6A3
collagen type VI alpha 3 chain
ISO
protein:increased expression:serum (human)
RGD
PMID:32245981
RGD:401900121
NCBI chr25:47,971,439...48,052,673
Ensembl chr25:47,971,315...48,052,402
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12133438 PMID:15955209
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr37:24,831,351...24,846,387
Ensembl chr37:24,843,171...24,844,247
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
mRNA:increased expression:peripheral blood immature plasma cells
RGD
PMID:21087446
RGD:6480657
NCBI chr X:55,882,433...55,884,582
Ensembl chr X:55,882,433...55,884,582
G
CXCR4
C-X-C motif chemokine receptor 4
ISO
mRNA:increased expression:peripheral blood immature plasma cells
RGD
PMID:21087446
RGD:6480657
NCBI chr19:38,874,650...38,877,740
Ensembl chr19:38,874,145...38,877,740
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
susceptibility
ISO
DNA:SNPs:multiple (human)
RGD
PMID:28811712
RGD:151665177
NCBI chr24:39,861,018...39,878,161
Ensembl chr24:39,862,355...39,878,216
G
DAP
death associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr34:3,616,960...3,682,424
Ensembl chr34:3,617,000...3,680,793
G
DLA-DQB1
major histocompatibility complex, class II, DQ beta 1
ISO
RGD
PMID:31038770
RGD:14865009
NCBI chr12:2,305,307...2,307,711
G
DPEP1
dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 5:63,909,034...63,923,309
Ensembl chr 5:63,909,042...63,923,492
G
DUOX2
dual oxidase 2
ISO
mRNA:increased expression:colon (human)
RGD
PMID:19759286
RGD:40924645
NCBI chr30:11,521,833...11,541,719
Ensembl chr30:11,521,845...11,541,716
G
ECM1
extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406
NCBI chr17:59,696,125...59,701,990
Ensembl chr17:59,696,477...59,701,744
G
EPHB2
EPH receptor B2
ameliorates
ISO
RGD
PMID:33722292
RGD:127285641
NCBI chr 2:76,427,112...76,551,494
Ensembl chr 2:76,428,203...76,612,786
G
ESR2
estrogen receptor 2
ISO
mRNA:decreased expression:colon
RGD
PMID:21252046
RGD:5508810
NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21593018
RGD:5147754
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:30122878
RGD:13792562
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:30122878
RGD:13792562
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
G
FGF7
fibroblast growth factor 7
ISO
mRNA:increased expression:colon, lamina propria, myofibroblasts (human)
RGD
PMID:9358773
RGD:126928145
NCBI chr30:15,555,016...15,608,230
Ensembl chr30:15,555,266...15,606,521
G
GC
GC vitamin D binding protein
susceptibility
ISO
DNA:polymorphism:cds:p.T420K(human)
RGD
PMID:21832969
RGD:5509866
NCBI chr13:60,795,305...60,828,038
Ensembl chr13:60,795,305...60,827,929
G
GHRL
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19617644
NCBI chr20:8,092,921...8,097,512
Ensembl chr20:8,092,957...8,097,510
G
GNA12
G protein subunit alpha 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 6:14,375,144...14,476,018
Ensembl chr 6:14,413,576...14,473,764
G
GPR65
G protein-coupled receptor 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30616622
NCBI chr 8:59,334,544...59,351,039
Ensembl chr 8:59,349,839...59,350,864
G
GPX1
glutathione peroxidase 1
ISO
protein:decreased expression:erythrocyte
RGD
PMID:20186929
RGD:11352754
NCBI chr20:39,889,165...39,890,253
Ensembl chr20:39,889,174...39,890,260
G
GPX2
glutathione peroxidase 2
disease_progression
ISO
protein:increased expression:large intestine (human)
RGD
PMID:18479189
RGD:152998902
NCBI chr 8:39,322,040...39,325,833
Ensembl chr 8:39,322,034...39,325,817
G
HERC2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 3:31,723,113...31,966,061
Ensembl chr 3:31,723,500...31,966,199
G
HLA-DRB1
MHC class II DLA DRB1 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25559196
NCBI chr12:2,151,409...2,164,564
G
HNF4A
hepatocyte nuclear factor 4 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr24:31,847,864...31,908,337
Ensembl chr24:31,847,961...31,905,916
G
HNMT
histamine N-methyltransferase
ISO
RGD
PMID:18340362
RGD:5509777
NCBI chr19:40,656,266...40,702,498
Ensembl chr19:40,655,161...40,702,218
G
HSPA4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:colon mucosa, epithelium (human)
RGD
PMID:22297444
RGD:5688753
NCBI chr11:21,290,603...21,363,701
Ensembl chr11:21,290,621...21,505,122
G
HTRA1
HtrA serine peptidase 1
ISO
protein:decreased expression:colonic epithelium,colonic mucosa (human)
RGD
PMID:28586045
RGD:152985530
NCBI chr28:32,133,779...32,157,835
Ensembl chr28:32,132,547...32,157,409
G
ICAM1
intercellular adhesion molecule 1
ISO
mRNA:increased expression:substantia nigra (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15553846 PMID:20584104
RGD:4145388
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
ICOSLG
inducible T cell costimulator ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr31:38,084,861...38,094,743
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:altered expression:colon
RGD
PMID:18938767
RGD:5686432
NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387
G
IGF2
insulin like growth factor 2
disease_progression
ISO
RGD
PMID:16088202
RGD:5509966
NCBI chr18:46,294,036...46,311,982
Ensembl chr18:46,294,019...46,311,982
G
IKZF1
IKAROS family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr18:1,661,851...1,750,987
Ensembl chr18:1,661,690...1,770,768
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18836448 PMID:20228799 PMID:26660358 PMID:28120341
RGD:14975153 RGD:14975255
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799 PMID:21297633
NCBI chr 4:51,178,637...51,194,606
Ensembl chr 4:51,183,568...51,193,228
G
IL17REL
interleukin 17 receptor E like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228798
NCBI chr10:17,238,418...17,242,686
Ensembl chr10:17,216,084...17,242,226
G
IL18RAP
interleukin 18 receptor accessory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr10:40,578,503...40,605,800
Ensembl chr10:40,581,096...40,605,766
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12133438 PMID:15955209 PMID:20452301 PMID:22119283 PMID:24812904
RGD:10450593
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1R2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr10:40,967,532...41,003,659
Ensembl chr10:40,896,669...41,034,113
G
IL1RN
interleukin 1 receptor antagonist
ISO
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human)
RGD
PMID:8119534
RGD:6909136
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
G
IL23R
interleukin 23 receptor
ISO
DNA:SNP,Haplotype: :rs1884444(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18438406 PMID:19122664 PMID:20228799 PMID:23093364
RGD:8549574
NCBI chr 5:43,307,422...43,369,806
Ensembl chr 5:43,308,982...43,368,474
G
IL33
interleukin 33
treatment severity
ISO
mRNA:increased expression:sigmoid colon
RGD
PMID:21037074 PMID:25112700 PMID:28802904
RGD:39938951 RGD:39938966 RGD:40813742
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
G
IL7R
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 4:72,633,528...72,668,242
Ensembl chr 4:72,636,325...72,668,300
G
IRF5
interferon regulatory factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr14:7,724,168...7,734,976
Ensembl chr14:7,724,780...7,742,795
G
JAK2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs10758669 (human)
CTD RGD
PMID:20228799 PMID:21297633 PMID:22269120
RGD:6483020
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
G
KIF21B
kinesin family member 21B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 7:2,185,040...2,231,046
Ensembl chr 7:2,184,733...2,231,058
G
LAMB1
laminin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr18:12,634,640...12,700,311
Ensembl chr18:12,630,554...12,700,308
G
LOC481473
immunity-related GTPase family M protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr11:793,416...795,373
Ensembl chr11:793,424...794,617
G
LSP1
lymphocyte specific protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr18:46,087,886...46,127,307
Ensembl chr18:46,087,922...46,127,263
G
LTF
lactotransferrin
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16640825 PMID:35999755
NCBI chr20:42,231,994...42,263,202
Ensembl chr20:42,231,994...42,263,202
G
MASP2
MBL associated serine protease 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12904520
NCBI chr 2:84,976,366...84,987,376
Ensembl chr 2:84,976,456...84,989,797
G
MIR155
microRNA mir-155
ISO
miRNA:decreased expression:feces miRNA:increased expression:colon
RGD
PMID:29325325 PMID:29438285 PMID:29668922 PMID:30927737
RGD:21079443 RGD:21403682 RGD:24922207 RGD:24922213
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR31
microRNA mir-31
ISO
miRNA:increased expression:colon
RGD
PMID:29438285
RGD:21403682
NCBI chr11:40,904,438...40,904,496
Ensembl chr11:40,904,437...40,904,503
G
MMP1
matrix metallopeptidase 1
ISO
RGD
PMID:18837084
RGD:7207395
NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22119283
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20380826 PMID:22119283 PMID:24055189
NCBI chr 9:32,927,483...32,938,007
Ensembl chr 9:32,927,483...32,937,820
G
MST1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799
NCBI chr20:39,582,237...39,586,958
Ensembl chr20:39,582,282...39,586,908
G
MTRR
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:polymorphism: :66A>G (human)
RGD
PMID:21947961
RGD:5508217
NCBI chr34:6,068,572...6,119,580
Ensembl chr34:6,070,046...6,098,312
G
MUC2
mucin 2, oligomeric mucus/gel-forming
ISO
mRNA:altered expression: :
RGD
PMID:12870797
RGD:2324685
NCBI chr18:45,416,347...45,438,226
G
NKX2-3
NK2 homeobox 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405 PMID:18438406 PMID:20228799
NCBI chr28:12,466,319...12,469,467
Ensembl chr28:12,466,368...12,469,473
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr 2:64,636,850...64,667,232
Ensembl chr 2:64,635,519...64,667,232
G
ORMDL3
ORMDL sphingolipid biosynthesis regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 9:22,594,425...22,601,108
Ensembl chr 9:22,594,480...22,599,999
G
PON1
paraoxonase 1
ISO
mRNA:decreased expression:colon
RGD
PMID:17664137
RGD:5509924
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
PON3
paraoxonase 3
ISO
mRNA:decreased expression:colon
RGD
PMID:17664137
RGD:5509924
NCBI chr14:20,615,180...20,642,807
Ensembl chr14:20,565,641...20,642,985
G
PRDM1
PR/SET domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr12:63,454,242...63,495,278
Ensembl chr12:63,470,974...63,495,579
G
PSMG1
proteasome assembly chaperone 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr31:33,914,640...33,925,925
Ensembl chr31:33,914,668...33,925,883
G
PTGER4
prostaglandin E receptor 4
ISO
RGD
PMID:21818367
RGD:6483532
NCBI chr 4:68,663,362...68,676,241
Ensembl chr 4:68,663,364...68,676,358
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
RGD
PMID:17429720
RGD:2300267
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:17429720
RGD:2300267
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
PTPN2
protein tyrosine phosphatase non-receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 7:78,160,564...78,252,382
Ensembl chr 7:78,160,589...78,252,719
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15955209
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
RIPK2
receptor interacting serine/threonine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr29:35,283,209...35,311,608
Ensembl chr29:35,282,072...35,311,333
G
SELL
selectin L
ISO
DNA:polymorphism: :p.F206L (human)
RGD
PMID:19212205
RGD:13464267
NCBI chr 7:28,906,752...28,927,959
Ensembl chr 7:28,906,809...29,094,008
G
SELP
selectin P
ISO
protein:increased expression:serum
RGD
PMID:21526498
RGD:6218993
NCBI chr 7:28,956,428...28,997,266
Ensembl chr 7:28,958,486...28,996,313
G
SLC11A1
solute carrier family 11 member 1
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human) DNA:transition, repeat:promoter:-237C>T (human)
CTD RGD
PMID:11929588 PMID:16059695 PMID:18340647
RGD:5684939 RGD:5684968
NCBI chr37:25,039,203...25,047,461
Ensembl chr37:25,038,360...25,047,282
G
SLC26A3
solute carrier family 26 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915573
NCBI chr18:12,817,177...12,843,502
Ensembl chr18:12,808,806...12,843,076
G
SPHK1
sphingosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr 9:4,311,698...4,314,773
Ensembl chr 9:4,311,683...4,314,483
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs744166 (human)
CTD RGD
PMID:18438405 PMID:20228799 PMID:22269120
RGD:6483020
NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
G
THBD
thrombomodulin
ISO
protein:decreased expression:colon, blood vessel
RGD
PMID:17557119
RGD:5685011
NCBI chr24:599,773...601,649
Ensembl chr24:599,773...601,649
G
TNF
tumor necrosis factor
treatment
ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19617644 PMID:20452301 PMID:22119283 PMID:24812904 PMID:25204186 PMID:28120341 More...
RGD:10450577 RGD:10450593 RGD:14975153
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFAIP3
TNF alpha induced protein 3
severity
ISO
mRNA,protein:increased expression, decreased expression:colonic mucosa (human)
RGD
PMID:28842689
RGD:151347619
NCBI chr 1:30,247,432...30,262,992
Ensembl chr 1:30,251,059...30,261,001
G
TNFSF15
TNF superfamily member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr11:68,887,858...68,909,406
Ensembl chr11:68,893,084...68,909,602
G
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15553846
NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:colon, plasma
RGD
PMID:19013462
RGD:5684406
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
VIP
vasoactive intestinal peptide
severity
ISO
mRNA:decreased expression:colon
RGD
PMID:22143367
RGD:5685619
NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
G
VIPR1
vasoactive intestinal peptide receptor 1
ISO
RGD
PMID:17611633
RGD:5685618
NCBI chr23:11,635,809...11,666,926
Ensembl chr23:11,635,394...11,666,936
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all